Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...

Bristol-Myers Squibb offers 17.25% upside with strong growth prospects, cost-saving initiatives & an undervalued stock. Learn ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will ...

Bristol Myers Squibb Co. closed 5.27% below its 52-week high of $63.33, which the company reached on March 11th.

We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 11,821 calls trading, 2x expected, and implied vol increasing almost 2 points to 27.82%. May-25 67.5 calls and Mar-25 60 calls are the ...

Bristol Myers Squibb, a global biopharmaceutical company, has appointed Osama Braiwish as its General Manager for Saudi ...

Bristol Myers Squibb (BMY) reachead $60.08 at the closing of the latest trading day, reflecting a +0.3% change compared to its last close.